Clover Health Investments Corp - Ordinary Shares - Class A Aktie News

Clover Health Investments, Corp. ( CLOV ) UBS Global Healthcare Conference 2025 November 11, 2025 11:00 AM EST Company Participants Peter Kuipers - Chief Financial Officer Presentation Unknown Analyst Okay. All right.

Clover Health Investments, Corp. ( CLOV ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Ryan Schmidt - Investor Relations Analyst Andrew Toy - Co-Founder, CEO & Director Peter Kuipers - Chief Financial Officer Conference Call Participants Jonathan Yong Presentation Operator Hello, and welcome to Clover Health's Third Quarter 2025 Earnings Call. [Operator Instructions] ...

Clover Health Investments (NASDAQ: CLOV) delivered its second consecutive profitable quarter tonight, beating earnings expectations and extending a streak of operational improvement that has quietly reshaped the Medicare Advantage insurer's narrative.

Business Highlights: Generates third quarter year-to-date positive Adjusted EBITDA profitability, on a wide network, while growing membership by 35% and revenue by 39% year-over-year, despite a greater proportion of new members relative to returning member base High coverage of Clover Assistant, including within new cohorts, will result in improved total cost of care Strong retention, above-mar...

WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that Chelsea Clinton, the longest-serving member of its Board of Directors, having joined the Board in early 2017, will conclude her service as of October 31, 2025.

New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease. New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease.

Clover's latest star rating downgrade was mainly driven by low member experience scores, which is an aspect it fully controls in its business. Despite low member experience scores, members' ratings for CLOV's health plan increased YoY, and fewer members are expected to leave its plan, which could offset new members' higher medical costs. The company's SaaS inflection point could be nearing thro...

WILMINGTON, Del., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 UBS Global Healthcare Conference on Tuesday, November 11, 2025, at 11:00 a.m. Eastern Time.